-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Trevi Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2021 to Q3 2025.
- Trevi Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.08 USD/shares, a 38.5% increase year-over-year.
- Trevi Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 0 USD/shares, a 15.9% increase year-over-year.
- Trevi Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -0.47 USD/shares, a 62.1% decline from 2023.
- Trevi Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.29 USD/shares, a 35.6% increase from 2022.
- Trevi Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.45 USD/shares, a 69.8% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)